Trial Better: A Clinical Trials Podcast

Otis Johnson, host of Trial Better, is joined by Dr. Eric Siemers, President of Siemers Integration, LLC and a Distinguished Medical Advisor at Cogstate. They explore the setbacks and progress in recent Alzheimer’s disease research, and why the industry has reason to be optimistic about breakthroughs in this field in the near future.

Host Otis Johnson sits down with Ken Getz, Founder and Chairman of CISCRP and a professor at the Tufts University School of Medicine. They discuss how the perception of clinical research has evolved during the COVID-19 pandemic, as well as what the industry can do to take advantage of this unique opportunity to improve its relationship with the public.

Trial Better host and ERT’s Vice President of Trial Oversight, Otis Johnson, is joined by Dan Brenner, founder and CEO of 1nHealth. They discuss the changing landscape of patient recruitment, and what sponsors should consider as they aim to develop digital recruitment strategies that reflect the patient voice and virtual platform.

Dr. Fabian Sandoval of the Emerson Clinical Research Institute shares his firsthand experiences and learnings on the topic of patient diversity in clinical research, including the importance of sharing both his successes and failures and important considerations for sites that want to improve the diversity of their patient populations.

Host Jason Eger is joined by Jim Kremidas, Executive Director of the Association of Clinical Research Professionals. They discuss trends in the clinical research workforce and why sponsors should be concerned about the future development pipeline, as well as changes the industry can make to better prepare individuals for successful clinical research careers.

Dr. Fabian Sandoval of the Emerson Clinical Research Institute shares his firsthand experiences and learnings on the topic of patient diversity in clinical research, including the importance of sharing both his successes and failures and important considerations for sites that want to improve the diversity of their patient populations.

Host Jason Eger is joined by Dr. Diana Foster, Vice President of Strategy and Special Projects at the Society for Clinical Research Sites, to discuss how clinical research sites can help the industry improve patient diversity in clinical research.

Trial Better host and ERT’s Director of Operational Readiness, Jason Eger, is joined by Mike Wenger, Vice President of Patient Engagement at TrialScope. As they discuss the roadblocks a patient faces when searching for the right clinical trial opportunity, they also explore changes the industry can make to improve the matching process.

ERT’s Todd Rudo is joined on this episode of Trial Better by guest Dr. Ignacio Rodriguez, Head of Patient Safety for Immunology, Hepatology, and Dermatology at Novartis. Together they shed light on clinical research in the time of COVID-19, patient safety, and how studies are changing to ensure data quality.

In this edition of Trial Better, Deborah Collyar, an oncology patient advocate, discusses the importance of patient advocacy in clinical trials and her own personal advocacy in oncology. Learn more about the role of a patient advocate and the long-term benefits of keeping the patients and their needs at the center of clinical trials.

ERT’s Brian Smith and AliveCor’s Dr. David Albert explore how technological advancements can not only offer solutions to problems caused by COVID-19, but change the landscape of clinical research even after the pandemic is over.

ERT’s Jason Eger, Nadeeka Dias, and Chris Watson explore technology-based solutions for the challenges of vaccine trials and address the biggest issue facing the clinical research community today: COVID-19.

Nick Conn of Heart Health Intelligence and Jean-Philippe Couderc of VPG Medical join Trial Better for an expanded discussion of new passive health monitoring technologies, including how new devices can pass regulatory scrutiny and the impact they’ll have on patients in clinical trials

ATS and ERS have updated their guidance for pulmonary function testing in both healthcare and clinical research in October 2019 for the first time since 2005. Kevin McCarthy from ERT, a member of the ATS/ERS 2019 Spirometry Update Task Force, joins Trial Better to define the purpose and implications of the guidance as well as its applications in clinical trials.

ERT’s Jason Eger and Phil Lake discuss clinical research industry trends and outlooks for respiratory solutions.

ERT’s Jason Eger and Amit Vasanji discuss clinical research industry trends and outlooks for imaging.

ERT’s Jason Eger and Ken Faulkner discuss clinical research industry trends and outlooks for eCOA.

ERT’s Jason Eger and Brian R. Smith discuss clinical research industry trends and outlooks for cardiac safety.

ERT’s Jason Eger and VPG Medical’s Jean-Philippe Couderc dive into the limitless potential and promise of passive health monitoring technologies in clinical trials.

Katy Jones from Greenphire discusses how the unification of two dynamic technology solutions can increase clinical trial patent engagement and produce positive outcomes for all stakeholders, potentially improving the patient experience and shortening the overall trial length.

Learn how to overcome one of the biggest concerns in the clinical trial industry - patient recruitment. In this episode, we’ll discuss the importance of precision recruitment and site-follow up, as well as patient recruitment challenges like diagnosis, eligibility, and diversity.

Phil Lake and Dr. Kai Michael-Beeh examine the steps sponsors and study teams can take to improve data quality and reduce data variability in respiratory trials. They also discuss the innovations and trends they expect to see in the industry in the future.

Ken Faulkner and Katarina Krosback explore the potential benefits and pitfalls of Bring Your Own Device (BYOD) in eCOA clinical trials, as well as the current regulatory perspective. In this episode we discuss the future hold of BYOD, the value of patients using their own devices and the technology needed for BYOD trials.

Patricia Castellano and Emily Olsson explore how sites can benefit from developing a stronger relationship with their ABPM device vendors. They also address strategies for successful repeat ABPM sessions when a patient is non-compliant, and how ABPM achieves a type of holistic data not possible with other BP measurement methods.

The FDA has identified ambulatory blood pressure monitoring as the best option for collecting data about the relationship between blood pressure changes and therapeutic drugs. In part one of our ABPM episodes, find out how to successfully capture ABPM data and improve patient compliance.

ERT’s Drew Bustos and Dr. Santikary discuss the challenges sponsors face due to increased demands for data, and examine how modern data platforms, cloud-based technologies, and artificial intelligence can provide potential solutions when incorporated into data integration and management plans.

Vivienne de Walle, Co-Founder of PT&R - a dedicated clinical trial site in the Netherlands, and Chris Porter, VP of Marketing & Digital Strategy, ERT, explore how involving clinical sites early on in the trial process can help simplify the study for sites, help sponsors avoid common, yet important, pitfalls and accelerate clinical trial timelines

ERT’s Brett Hoover and Amit Vasanji examine the massive growth trends in demand for imaging and discuss how sponsors and CROs can develop strategies and incorporate technologies that enable them to achieve better, more thorough, and less costly imaging data.

The difference between good and better is experience. With nearly 50 years of experience, ERT is not afraid to ask tough questions. We are proud to bring together respected professionals to exchange new perspectives. Trial Better – a clinical trials best practices series. #trialbetter